Niagen Bioscience (NAGE) Change in Account Payables (2011 - 2026)

Niagen Bioscience (NAGE) has reported Change in Account Payables for 14 consecutive years, with $2.5 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Change in Account Payables rose 17.81% year-over-year to $2.5 million; the TTM figure through Mar 2026 stood at $2.6 million (down 21.56% YoY), while the FY2025 annual figure was $2.3 million, up 312.75% from the prior year.
• Change in Account Payables climbed to $2.5 million in Q1 2026 per NAGE's latest filing, from -$1.9 million in the prior quarter.
• Across five years, Change in Account Payables topped out at $3.0 million in Q2 2025 and bottomed at -$2.3 million in Q1 2024.
• Historically, Change in Account Payables has averaged $205470.6 across 5 years, with a median of $206000.0 in 2024.
• Annual changes were most pronounced in 2022 — Change in Account Payables tumbled 229.26% — and 2025, when it soared 1379.61%.
• Niagen Bioscience's Change in Account Payables stood at $560000.0 in 2022, then surged by 84.64% to $1.0 million in 2023, then soared by 118.76% to $2.3 million in 2024, then sank by 186.03% to -$1.9 million in 2025, then surged by 227.49% to $2.5 million in 2026.
• Business Quant data shows NAGE's Change in Account Payables at $2.5 million in Q1 2026, -$1.9 million in Q4 2025, and -$938000.0 in Q3 2025.